Kyongbo Pharmaceutical Co., Ltd 214390.KS Stock
Kyongbo Pharmaceutical Co., Ltd Price Chart
Kyongbo Pharmaceutical Co., Ltd 214390.KS Financial and Trading Overview
Kyongbo Pharmaceutical Co., Ltd stock price | 7440 KRW |
Previous Close | 6910 KRW |
Open | 6900 KRW |
Bid | 7010 KRW x 0 |
Ask | 7030 KRW x 0 |
Day's Range | 6890 - 7140 KRW |
52 Week Range | 4875 - 10950 KRW |
Volume | 38.1K KRW |
Avg. Volume | 301.39K KRW |
Market Cap | 168.07B KRW |
Beta (5Y Monthly) | 1.103424 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 50 (0.67%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
214390.KS Valuation Measures
Enterprise Value | 233.83B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.8352991 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.162 |
Enterprise Value/EBITDA | 17.724 |
Trading Information
Kyongbo Pharmaceutical Co., Ltd Stock Price History
Beta (5Y Monthly) | 1.103424 |
52-Week Change | -1.28% |
S&P500 52-Week Change | 20.43% |
52 Week High | 10950 KRW |
52 Week Low | 4875 KRW |
50-Day Moving Average | 7152.8 KRW |
200-Day Moving Average | 6867.68 KRW |
214390.KS Share Statistics
Avg. Volume (3 month) | 301.39K KRW |
Avg. Daily Volume (10-Days) | 98.2K KRW |
Shares Outstanding | 23.91M |
Float | 9.08M |
Short Ratio | N/A |
% Held by Insiders | 62.09% |
% Held by Institutions | 0.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 124.00% |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -0.14% |
Operating Margin (ttm) | 0.78% |
Gross Margin | 23.41% |
EBITDA Margin | 6.55% |
Management Effectiveness
Return on Assets (ttm) | 0.41% |
Return on Equity (ttm) | -0.20% |
Income Statement
Revenue (ttm) | 201.2B KRW |
Revenue Per Share (ttm) | 8320.27 KRW |
Quarterly Revenue Growth (yoy) | 11.50% |
Gross Profit (ttm) | 43.87B KRW |
EBITDA | 13.19B KRW |
Net Income Avi to Common (ttm) | -288917664 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 11.5B KRW |
Total Cash Per Share (mrq) | 481 KRW |
Total Debt (mrq) | 70.1B KRW |
Total Debt/Equity (mrq) | 49.62 KRW |
Current Ratio (mrq) | 1.152 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 10.06B KRW |
Levered Free Cash Flow (ttm) | 46.73M KRW |
Profile of Kyongbo Pharmaceutical Co., Ltd
Country | South Korea |
State | N/A |
City | Asan |
Address | 174, Sirok-ro |
ZIP | N/A |
Phone | 82 4 1420 0500 |
Website | https://www.kbpharma.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients in South Korea. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also exports its products to 30 countries worldwide. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan, South Korea.
Q&A For Kyongbo Pharmaceutical Co., Ltd Stock
What is a current 214390.KS stock price?
Kyongbo Pharmaceutical Co., Ltd 214390.KS stock price today per share is 7440 KRW.
How to purchase Kyongbo Pharmaceutical Co., Ltd stock?
You can buy 214390.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kyongbo Pharmaceutical Co., Ltd?
The stock symbol or ticker of Kyongbo Pharmaceutical Co., Ltd is 214390.KS.
Which industry does the Kyongbo Pharmaceutical Co., Ltd company belong to?
The Kyongbo Pharmaceutical Co., Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Kyongbo Pharmaceutical Co., Ltd have in circulation?
The max supply of Kyongbo Pharmaceutical Co., Ltd shares is 23.91M.
What is Kyongbo Pharmaceutical Co., Ltd Price to Earnings Ratio (PE Ratio)?
Kyongbo Pharmaceutical Co., Ltd PE Ratio is now.
What was Kyongbo Pharmaceutical Co., Ltd earnings per share over the trailing 12 months (TTM)?
Kyongbo Pharmaceutical Co., Ltd EPS is 0 KRW over the trailing 12 months.
Which sector does the Kyongbo Pharmaceutical Co., Ltd company belong to?
The Kyongbo Pharmaceutical Co., Ltd sector is Healthcare.